Correlation Between Mandom Indonesia and Millennium Pharmacon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mandom Indonesia and Millennium Pharmacon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mandom Indonesia and Millennium Pharmacon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mandom Indonesia Tbk and Millennium Pharmacon International, you can compare the effects of market volatilities on Mandom Indonesia and Millennium Pharmacon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mandom Indonesia with a short position of Millennium Pharmacon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mandom Indonesia and Millennium Pharmacon.

Diversification Opportunities for Mandom Indonesia and Millennium Pharmacon

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Mandom and Millennium is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Mandom Indonesia Tbk and Millennium Pharmacon Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Millennium Pharmacon and Mandom Indonesia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mandom Indonesia Tbk are associated (or correlated) with Millennium Pharmacon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Millennium Pharmacon has no effect on the direction of Mandom Indonesia i.e., Mandom Indonesia and Millennium Pharmacon go up and down completely randomly.

Pair Corralation between Mandom Indonesia and Millennium Pharmacon

Assuming the 90 days trading horizon Mandom Indonesia Tbk is expected to under-perform the Millennium Pharmacon. But the stock apears to be less risky and, when comparing its historical volatility, Mandom Indonesia Tbk is 2.01 times less risky than Millennium Pharmacon. The stock trades about -0.1 of its potential returns per unit of risk. The Millennium Pharmacon International is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  13,400  in Millennium Pharmacon International on August 28, 2024 and sell it today you would earn a total of  2,400  from holding Millennium Pharmacon International or generate 17.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Mandom Indonesia Tbk  vs.  Millennium Pharmacon Internati

 Performance 
       Timeline  
Mandom Indonesia Tbk 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mandom Indonesia Tbk has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's forward-looking signals remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Millennium Pharmacon 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Millennium Pharmacon International are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting forward-looking signals, Millennium Pharmacon disclosed solid returns over the last few months and may actually be approaching a breakup point.

Mandom Indonesia and Millennium Pharmacon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mandom Indonesia and Millennium Pharmacon

The main advantage of trading using opposite Mandom Indonesia and Millennium Pharmacon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mandom Indonesia position performs unexpectedly, Millennium Pharmacon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Millennium Pharmacon will offset losses from the drop in Millennium Pharmacon's long position.
The idea behind Mandom Indonesia Tbk and Millennium Pharmacon International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital